Rankings
▼
Calendar
TARS Q3 2019 Earnings — Tarsus Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
TARS
Tarsus Pharmaceuticals, Inc.
$3B
Q3 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$20,000
Operating Income
-$633,000
Net Income
-$681,000
EPS (Diluted)
$-0.06
Cash Flow
Operating Cash Flow
-$570,000
Free Cash Flow
-$576,000
Stock-Based Comp.
$4,000
← FY 2019
All Quarters
Q4 2019 →
